Statins and hepatotoxicity: Focus on patients with fatty liver

[1] Use and monitoring of "statin" lipid-lowering drugs compared with guidelines [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) : 53 - 58

[2] Fatty infiltration of liver in hyperlipidemic patients [J]. DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (10) : 1929 - 1934

[3] Safety of statins - Focus on clinical pharmacokinetics and drug interactions [J]. CIRCULATION, 2004, 109 (23) : 50 - 57

[4] Do statins cause cancer? A meta-analysis of large randomized clinical trials [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 110 (09) : 716 - 723

[5] Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors -: The role of metabolism -: Monograph for physicians [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (15) : 2273 - 2280

[6] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395

[7] Burdick L, 2004, HEPATOLOGY, V40, p589A

[8] The liver and statin drug therapy: uncertain navigation in the sea of risk-benefit [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (04) : 303 - 306

[9] Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08) : 1497 - 1502

[10] Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity [J]. GASTROENTEROLOGY, 2004, 126 (05) : 1287 - 1292

[1] Use and monitoring of "statin" lipid-lowering drugs compared with guidelines [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) : 53 - 58

[2] Fatty infiltration of liver in hyperlipidemic patients [J]. DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (10) : 1929 - 1934

[3] Safety of statins - Focus on clinical pharmacokinetics and drug interactions [J]. CIRCULATION, 2004, 109 (23) : 50 - 57

[4] Do statins cause cancer? A meta-analysis of large randomized clinical trials [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 110 (09) : 716 - 723

[5] Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors -: The role of metabolism -: Monograph for physicians [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (15) : 2273 - 2280

[6] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395

[7] Burdick L, 2004, HEPATOLOGY, V40, p589A

[8] The liver and statin drug therapy: uncertain navigation in the sea of risk-benefit [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2003, 12 (04) : 303 - 306

[9] Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08) : 1497 - 1502

[10] Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity [J]. GASTROENTEROLOGY, 2004, 126 (05) : 1287 - 1292